StockData
TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (TXMD) stock

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.91+0.10 (+5.52%)

Close on Nov 17, 2026Market cap $22.11MP/E –Yield –

TherapeuticsMD revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

TherapeuticsMD's revenue for the twelve months ending Jun 30, 2026 was $3.27M, up 27.8% year over year. For fiscal 2025 it was $3.02M, up 71.6% from the year before. Over ten years it grew -17.3% a year on average. The highest annual figure on record is $69.96M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.02M+71.6%
FY2024Dec 31, 2024$1.76M+35.3%
FY2023Dec 31, 2023$1.30M-98.1%
FY2022Dec 31, 2022$69.96M+2619.1%
FY2021Dec 31, 2021$2.57M-96.0%
FY2020Dec 31, 2020$64.87M+30.7%
FY2019Dec 31, 2019$49.65M+208.4%
FY2018Dec 31, 2018$16.10M-4.0%
FY2017Dec 31, 2017$16.78M-13.3%
FY2016Dec 31, 2016$19.36M-3.9%
FY2015Dec 31, 2015$20.14M+34.1%
FY2014Dec 31, 2014$15.03M+71.2%
FY2013Dec 31, 2013$8.78M+129.8%
FY2012Dec 31, 2012$3.82M+82.8%
FY2011Dec 31, 2011$2.09M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$869.00K-8.7%
Q1 FY2026Mar 31, 2026$724.00K+84.2%
Q4 FY2025Dec 31, 2025$893.00K+33.9%
Q3 FY2025Sep 30, 2025$784.00K+43.3%
Q2 FY2025Jun 30, 2025$952.00K+306.8%
Q1 FY2025Mar 31, 2025$393.00K+25.6%
Q4 FY2024Dec 31, 2024$667.00K+32.9%
Q3 FY2024Sep 30, 2024$547.00K–
Q2 FY2024Jun 30, 2024$234.00K-46.5%
Q1 FY2024Mar 31, 2024$313.00K-24.8%
Q4 FY2023Dec 31, 2023$502.00K-99.3%
Q3 FY2023Sep 30, 2023-$53.00K-115.0%
Q2 FY2023Jun 30, 2023$437.00K+25.6%
Q1 FY2023Mar 31, 2023$416.00K-40.1%
Q4 FY2022Dec 31, 2022$68.57M+267.1%
Q3 FY2022Sep 30, 2022$354.00K-98.6%
Q2 FY2022Jun 30, 2022$348.00K-98.5%
Q1 FY2022Mar 31, 2022$695.00K-96.5%
Q4 FY2021Dec 31, 2021$18.68M-17.3%
Q3 FY2021Sep 30, 2021$25.41M+31.4%
Q2 FY2021Jun 30, 2021$23.00M+114.9%
Q1 FY2021Mar 31, 2021$19.87M+62.2%
Q4 FY2020Dec 31, 2020$22.58M+42.0%
Q3 FY2020Sep 30, 2020$19.34M-18.5%
Q2 FY2020Jun 30, 2020$10.70M+76.0%
Q1 FY2020Mar 31, 2020$12.25M+210.4%
Q4 FY2019Dec 31, 2019$15.90M+212.5%
Q3 FY2019Sep 30, 2019$23.72M+582.8%
Q2 FY2019Jun 30, 2019$6.08M+61.5%
Q1 FY2019Mar 31, 2019$3.95M+4.6%
Q4 FY2018Dec 31, 2018$5.09M+23.4%
Q3 FY2018Sep 30, 2018$3.47M-21.4%
Q2 FY2018Jun 30, 2018$3.76M-11.5%
Q1 FY2018Mar 31, 2018$3.77M-5.3%
Q4 FY2017Dec 31, 2017$4.13M-8.1%
Q3 FY2017Sep 30, 2017$4.42M-20.2%
Q2 FY2017Jun 30, 2017$4.25M–
Q1 FY2017Mar 31, 2017$3.99M–
Q4 FY2016Dec 31, 2016$4.49M–
Q3 FY2016Sep 30, 2016$5.54M–

More TherapeuticsMD figures

See a number that looks wrong?